ZIVO Bioscience, Inc.
ZIVO Bioscience, Inc.
Your view on ZIVOW
Overview
What the company does, where it operates, and who runs it.
About ZIVO Bioscience, Inc.
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- John Bernard Payne
- Headquarters
- 21 East Long Lake Road, Bloomfield Hills, MI, US
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- John Bernard Payne
- Headquarters
- 21 East Long Lake Road, Bloomfield Hills, MI, US
ZIVO Bioscience, Inc. is a research and development firm specializing in the creation, licensing, and distribution of natural bioactive compounds. These ingredients, derived from its exclusive algal strains, are supplied to manufacturers across the animal health, human health, dietary supplement, and medical food sectors. Active across the biotechnology and agricultural technology domains, ZIVO possesses a comprehensive intellectual property estate. This encompasses unique algal and bacterial strains, novel biologically active molecules and complexes, specialized production and cultivation methodologies, and a suite of patented or patent-pending innovations designed for both human and animal health solutions. The company's offerings address a diverse range of health concerns, such as promoting gut health in poultry, combating bovine mastitis, enhancing joint function in canines, modulating human immune responses, providing algal biomass for direct human consumption, and supporting skin vitality and anti-aging efforts. Previously operating as Health Enhancement Products, Inc., the firm adopted the ZIVO Bioscience, Inc. name in October 2014. Its corporate headquarters are situated in Bloomfield Hills, Michigan.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks the stock is worth vs. the current price.
FRC's fair value estimate for ZIVO Bioscience, Inc., and the rating behind it. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for ZIVO Bioscience, Inc.. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for ZIVO Bioscience, Inc.. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for ZIVO Bioscience, Inc.. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for ZIVO Bioscience, Inc.. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
ZIVO Bioscience, Inc. valued side by side against its closest peers. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
Which funds and firms own the stock.
Which institutions hold ZIVO Bioscience, Inc., and how their positions are changing. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.
Insider Trading
Recent buying and selling by company executives.
Buying and selling by ZIVO Bioscience, Inc. executives and directors. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.
Senate Trading
U.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming ZIVO Bioscience, Inc.. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely.
House Trading
U.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming ZIVO Bioscience, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals.
News
Latest headlines and market coverage.
Latest headlines and company announcements for ZIVO Bioscience, Inc.. Press releases and market coverage, newest first.